Menu

FDA rejects cancer drug invented in China in blow to Beijing’s biotech sector
📰

FDA rejects cancer drug invented in China in blow to Beijing’s biotech sector

International homepage·about 15 hours ago
#xf6Y2b7X
Reading 0:00
15s threshold

Summit’s Ivonescimab was seen as a test case for whether the country’s medicine could pass scrutiny in the US

Anonymous readers can preview up to 1024 characters here. Log in to unlock the full article once ingest succeeds.